FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130297201> ?p ?o ?g. }

• W2130297201 endingPage "257" @default.
• W2130297201 startingPage "248" @default.
• W2130297201 abstract "To systematically evaluate the clinical consequences of mycophenolate dose reduction in renal transplant recipients on tacrolimus-based regimens.PubMed (1949-July 2010), EMBASE (1980-July 2010), Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, and Web of Science were searched using the terms mycophenolate mofetil, tacrolimus, dose reduction, and kidney and/or renal transplant. References from publications identified were reviewed.Studies reporting on rejection rate, allograft survival, or renal function were included and ranked according to the US Preventive Services Task Force classification; excluded were studies that were dose-finding or used cyclosporine only, involved patients on enteric-coated mycophenolate sodium or those with multiorgan transplant, or provided no information on concomitant immunosuppressants. Data extracted were study design, sample size, immunosuppression regimen, type of transplant, and allograft outcomes.Of 13 studies included, 1 was level I evidence, 3 were level II-2, 6 were level II-3, and 3 were level III evidence. Three focused on tacrolimus-based regimens, whereas 7 included either cyclosporine or tacrolimus. The only prospective, randomized, multicenter trial demonstrated that early taper of mycophenolate dosage to 1 g/day can be utilized without increased risk of rejection, compared with late tapering, but the rejection rate was high (30-40%). Overall, we found conflicting evidence regarding the impact of mycophenolate dose reduction on rejection rate and allograft loss and that discontinuing mycophenolate led to an increased risk of graft loss as high as 8 fold. Allograft survival was lowest in patients with gastrointestinal complications and those in whom mycophenolate was discontinued, compared with patients with neither gastrointestinal complications nor mycophenolate discontinuation.Weak evidence suggests that mycophenolate dose modifications, either reduction or discontinuation, may increase rejection rate and graft loss; however, this is more apparent in cyclosporine-based regimens. Prospective, well-designed trials are necessary to definitively determine the impact of dose reduction in renal transplant recipients on tacrolimus-based regimens." @default.
• W2130297201 created "2016-06-24" @default.
• W2130297201 creator A5010826121 @default.
• W2130297201 creator A5013349961 @default.
• W2130297201 creator A5073337287 @default.
• W2130297201 date "2011-02-01" @default.
• W2130297201 modified "2023-09-30" @default.
• W2130297201 title "Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review" @default.
• W2130297201 cites W1585989097 @default.
• W2130297201 cites W1782008537 @default.
• W2130297201 cites W1965931571 @default.
• W2130297201 cites W1968700398 @default.
• W2130297201 cites W1969532140 @default.
• W2130297201 cites W1971278669 @default.
• W2130297201 cites W1977963723 @default.
• W2130297201 cites W1987999831 @default.
• W2130297201 cites W1990541454 @default.
• W2130297201 cites W1996853835 @default.
• W2130297201 cites W1998099663 @default.
• W2130297201 cites W1999294805 @default.
• W2130297201 cites W2001349326 @default.
• W2130297201 cites W2011178646 @default.
• W2130297201 cites W2014546665 @default.
• W2130297201 cites W2018384104 @default.
• W2130297201 cites W2020224358 @default.
• W2130297201 cites W2022531506 @default.
• W2130297201 cites W2034574115 @default.
• W2130297201 cites W2037132901 @default.
• W2130297201 cites W2039057937 @default.
• W2130297201 cites W2056445099 @default.
• W2130297201 cites W2057516516 @default.
• W2130297201 cites W2069503528 @default.
• W2130297201 cites W2072589111 @default.
• W2130297201 cites W2083580121 @default.
• W2130297201 cites W2086046058 @default.
• W2130297201 cites W2093825703 @default.
• W2130297201 cites W2100939580 @default.
• W2130297201 cites W2105306495 @default.
• W2130297201 cites W2121922479 @default.
• W2130297201 cites W2131017985 @default.
• W2130297201 cites W2131290131 @default.
• W2130297201 cites W2167078188 @default.
• W2130297201 cites W2171923114 @default.
• W2130297201 cites W2336236972 @default.
• W2130297201 cites W2609602266 @default.
• W2130297201 cites W32301231 @default.
• W2130297201 cites W4230996310 @default.
• W2130297201 cites W4235172700 @default.
• W2130297201 cites W50336179 @default.
• W2130297201 doi "https://doi.org/10.1345/aph.1p456" @default.
• W2130297201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21304036" @default.
• W2130297201 hasPublicationYear "2011" @default.
• W2130297201 type Work @default.
• W2130297201 sameAs 2130297201 @default.
• W2130297201 citedByCount "11" @default.
• W2130297201 countsByYear W21302972012013 @default.
• W2130297201 countsByYear W21302972012016 @default.
• W2130297201 countsByYear W21302972012017 @default.
• W2130297201 countsByYear W21302972012019 @default.
• W2130297201 countsByYear W21302972012020 @default.
• W2130297201 countsByYear W21302972012021 @default.
• W2130297201 countsByYear W21302972012022 @default.
• W2130297201 crossrefType "journal-article" @default.
• W2130297201 hasAuthorship W2130297201A5010826121 @default.
• W2130297201 hasAuthorship W2130297201A5013349961 @default.
• W2130297201 hasAuthorship W2130297201A5073337287 @default.
• W2130297201 hasConcept C126322002 @default.
• W2130297201 hasConcept C126894567 @default.
• W2130297201 hasConcept C141071460 @default.
• W2130297201 hasConcept C2778033501 @default.
• W2130297201 hasConcept C2779384505 @default.
• W2130297201 hasConcept C2780252810 @default.
• W2130297201 hasConcept C2781413609 @default.
• W2130297201 hasConcept C2909675724 @default.
• W2130297201 hasConcept C2909935303 @default.
• W2130297201 hasConcept C2911091166 @default.
• W2130297201 hasConcept C71924100 @default.
• W2130297201 hasConcept C90924648 @default.
• W2130297201 hasConceptScore W2130297201C126322002 @default.
• W2130297201 hasConceptScore W2130297201C126894567 @default.
• W2130297201 hasConceptScore W2130297201C141071460 @default.
• W2130297201 hasConceptScore W2130297201C2778033501 @default.
• W2130297201 hasConceptScore W2130297201C2779384505 @default.
• W2130297201 hasConceptScore W2130297201C2780252810 @default.
• W2130297201 hasConceptScore W2130297201C2781413609 @default.
• W2130297201 hasConceptScore W2130297201C2909675724 @default.
• W2130297201 hasConceptScore W2130297201C2909935303 @default.
• W2130297201 hasConceptScore W2130297201C2911091166 @default.
• W2130297201 hasConceptScore W2130297201C71924100 @default.
• W2130297201 hasConceptScore W2130297201C90924648 @default.
• W2130297201 hasIssue "2" @default.
• W2130297201 hasLocation W21302972011 @default.
• W2130297201 hasLocation W21302972012 @default.
• W2130297201 hasOpenAccess W2130297201 @default.
• W2130297201 hasPrimaryLocation W21302972011 @default.
• W2130297201 hasRelatedWork W1984170845 @default.
• W2130297201 hasRelatedWork W1991679644 @default.
• W2130297201 hasRelatedWork W1992117911 @default.

• next